Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bartmeyer

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Plos One|June 4, 2014
Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter CohortAndrea Hauser, Claudia Santos-Hoevener, Karolin Meixenberger, et al.
AIDS (London, England)|August 6, 2013
Natural history of HIV-control since seroconversionYoann Madec, Faroudy Boufassa, Kholoud Porter, et al.
Journal of Virological Methods|February 11, 2019
Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spotsAndrea Hauser, Matthias An der Heiden, Karolin Meixenberger, et al.
Journal of Clinical Microbiology|June 13, 2014
Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studiesKarolin Meixenberger, Andrea Hauser, Klaus Jansen, et al.
Journal of Immunological Methods|January 21, 2020
Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spotsAmare Eshetu, Andrea Hauser, Matthias An der Heiden, et al.
AIDS (London, England)|December 31, 2008
A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progressionDjin-Ye Oh, Konstantin Baumann, Osamah Hamouda, et al.
AIDS Research and Human Retroviruses|March 14, 2020
Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis AccessibilityPatryk Mysior, Erik Tenberken, Melanie Stecher, et al.
Journal of Virology|April 5, 2019
Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in GermanyKirsten Hanke, Nuno Rodrigues Faria, Denise Kühnert, et al.
Plos One|August 23, 2014
Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in GermanyDaniel Schmidt, Christian Kollan, Gerd Fätkenheuer, et al.
Plos One|September 21, 2011
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohortMatthias Stoll, Christian Kollan, Frank Bergmann, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos One|June 4, 2014
Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter CohortAndrea Hauser, Claudia Santos-Hoevener, Karolin Meixenberger, et al.
AIDS (London, England)|August 6, 2013
Natural history of HIV-control since seroconversionYoann Madec, Faroudy Boufassa, Kholoud Porter, et al.
Journal of Virological Methods|February 11, 2019
Evaluation of a BioRad Avidity assay for identification of recent HIV-1 infections using dried serum or plasma spotsAndrea Hauser, Matthias An der Heiden, Karolin Meixenberger, et al.
Journal of Clinical Microbiology|June 13, 2014
Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studiesKarolin Meixenberger, Andrea Hauser, Klaus Jansen, et al.
Journal of Immunological Methods|January 21, 2020
Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spotsAmare Eshetu, Andrea Hauser, Matthias An der Heiden, et al.
AIDS (London, England)|December 31, 2008
A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progressionDjin-Ye Oh, Konstantin Baumann, Osamah Hamouda, et al.
AIDS Research and Human Retroviruses|March 14, 2020
Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis AccessibilityPatryk Mysior, Erik Tenberken, Melanie Stecher, et al.
Journal of Virology|April 5, 2019
Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in GermanyKirsten Hanke, Nuno Rodrigues Faria, Denise Kühnert, et al.
Plos One|August 23, 2014
Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in GermanyDaniel Schmidt, Christian Kollan, Gerd Fätkenheuer, et al.
Plos One|September 21, 2011
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohortMatthias Stoll, Christian Kollan, Frank Bergmann, et al.
Pageof 4